Related Experiment Video
Updated: Nov 6, 2025

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
Peripheral-specific Y1 receptor antagonism increases thermogenesis and protects against diet-induced obesity
Chenxu Yan1,2, Tianshu Zeng3, Kailun Lee1
1Neuroscience Division, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.
Abstract:
Obesity is caused by an imbalance between food intake and energy expenditure (EE). Here we identify a conserved pathway that links signalling through peripheral Y1 receptors (Y1R) to the control of EE. Selective antagonism of peripheral Y1R, via the non-brain penetrable antagonist BIBO3304, leads to a significant reduction in body weight gain due to enhanced EE thereby reducing fat mass. Specifically thermogenesis in brown adipose tissue (BAT) due to elevated UCP1 is enhanced accompanied by extensive browning of white adipose tissue both in mice and humans. Importantly, selective ablation of Y1R from adipocytes protects against diet-induced obesity. Furthermore, peripheral specific Y1R antagonism also improves glucose homeostasis mainly driven by dynamic changes in Akt activity in BAT. Together, these data suggest that selective peripheral only Y1R antagonism via BIBO3304, or a functional analogue, could be developed as a safer and more effective treatment option to mitigate diet-induced obesity.
Insights
Blocking peripheral Y1 receptors (Y1R) enhances energy expenditure and reduces fat mass, offering a potential new obesity treatment. This approach improves glucose homeostasis by targeting Y1R in fat cells.
Area of Science:
- Metabolism and Endocrinology
- Obesity Research
- Adipose Tissue Biology
Background:
- Obesity arises from an energy intake and expenditure imbalance.
- Peripheral Y1 receptors (Y1R) are implicated in energy balance regulation.
Purpose of the Study:
- To investigate the role of peripheral Y1R signaling in controlling energy expenditure (EE).
- To evaluate the therapeutic potential of selective peripheral Y1R antagonism for obesity and metabolic dysfunction.
Main Methods:
- Administration of BIBO3304, a non-brain penetrant Y1R antagonist, in mice.
- Assessment of body weight, energy expenditure, and adipose tissue characteristics (thermogenesis, UCP1, browning).
- Selective Y1R ablation in adipocytes and analysis of glucose homeostasis and Akt activity in brown adipose tissue (BAT).
Main Results:
- Selective peripheral Y1R antagonism significantly reduced body weight gain by enhancing EE.
- Increased thermogenesis in brown adipose tissue (BAT) and white adipose tissue (WAT) browning were observed.
- Y1R ablation in adipocytes protected against diet-induced obesity and improved glucose homeostasis.
Conclusions:
- Peripheral Y1R signaling is a key regulator of energy expenditure and fat mass.
- Selective peripheral Y1R antagonism, exemplified by BIBO3304, represents a promising therapeutic strategy for obesity.
- Targeting Y1R in adipocytes offers a novel approach to improve metabolic health and combat obesity.
Related Concept Videos
Thermoregulation
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Regulation of Food Intake
GPCRs Regulate Adenylyl Cylase Activity
Thermosensation
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

